290 related articles for article (PubMed ID: 18802476)
1. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs.
Lüth S; Huber S; Schramm C; Buch T; Zander S; Stadelmann C; Brück W; Wraith DC; Herkel J; Lohse AW
J Clin Invest; 2008 Oct; 118(10):3403-10. PubMed ID: 18802476
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice.
Carambia A; Freund B; Schwinge D; Bruns OT; Salmen SC; Ittrich H; Reimer R; Heine M; Huber S; Waurisch C; Eychmüller A; Wraith DC; Korn T; Nielsen P; Weller H; Schramm C; Lüth S; Lohse AW; Heeren J; Herkel J
J Hepatol; 2015 Jun; 62(6):1349-56. PubMed ID: 25617499
[TBL] [Abstract][Full Text] [Related]
3. Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.
Kim YC; Zhang AH; Yoon J; Culp WE; Lees JR; Wucherpfennig KW; Scott DW
J Autoimmun; 2018 Aug; 92():77-86. PubMed ID: 29857928
[TBL] [Abstract][Full Text] [Related]
4. Experimental autoimmune encephalomyelitis in mice expressing the autoantigen MBP 1-10 covalently bound to the MHC class II molecule I-Au.
Kurschus FC; Oelert T; Liliensiek B; Buchmann P; Wraith DC; Hämmerling GJ; Arnold B
Int Immunol; 2006 Jan; 18(1):151-62. PubMed ID: 16361316
[TBL] [Abstract][Full Text] [Related]
5. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice.
Carrier Y; Yuan J; Kuchroo VK; Weiner HL
J Immunol; 2007 Jan; 178(1):179-85. PubMed ID: 17182553
[TBL] [Abstract][Full Text] [Related]
6. The thymus plays a role in oral tolerance in experimental autoimmune encephalomyelitis.
Song F; Guan Z; Gienapp IE; Shawler T; Benson J; Whitacre CC
J Immunol; 2006 Aug; 177(3):1500-9. PubMed ID: 16849456
[TBL] [Abstract][Full Text] [Related]
7. Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression.
De Paula Pohl A; Schmidt A; Zhang AH; Maldonado T; Königs C; Scott DW
Cell Immunol; 2020 Dec; 358():104222. PubMed ID: 33053469
[TBL] [Abstract][Full Text] [Related]
8. Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg.
Stephens LA; Malpass KH; Anderton SM
Eur J Immunol; 2009 Apr; 39(4):1108-17. PubMed ID: 19350586
[TBL] [Abstract][Full Text] [Related]
9. Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit.
Costa GL; Sandora MR; Nakajima A; Nguyen EV; Taylor-Edwards C; Slavin AJ; Contag CH; Fathman CG; Benson JM
J Immunol; 2001 Aug; 167(4):2379-87. PubMed ID: 11490028
[TBL] [Abstract][Full Text] [Related]
10. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
Zierden M; Kühnen E; Odenthal M; Dienes HP
Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
[TBL] [Abstract][Full Text] [Related]
11. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
Front Immunol; 2018; 9():3119. PubMed ID: 30687323
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE).
Kumar V; Stellrecht K; Sercarz E
J Exp Med; 1996 Nov; 184(5):1609-17. PubMed ID: 8920851
[TBL] [Abstract][Full Text] [Related]
13. LF 15-0195 inhibits the development of rat central nervous system autoimmunity by inducing long-lasting tolerance in autoreactive CD4 T cells.
Duplan V; Dutartre P; Mars LT; Liblau RS; Druet P; Saoudi A
J Immunol; 2003 Feb; 170(4):2179-85. PubMed ID: 12574391
[TBL] [Abstract][Full Text] [Related]
14. Failure of thymic deletion and instability of autoreactive Tregs drive autoimmunity in immune-privileged liver.
Preti M; Schlott L; Lübbering D; Krzikalla D; Müller AL; Schuran FA; Poch T; Schakat M; Weidemann S; Lohse AW; Weiler-Normann C; Sebode M; Schwinge D; Schramm C; Carambia A; Herkel J
JCI Insight; 2021 Mar; 6(6):. PubMed ID: 33600378
[TBL] [Abstract][Full Text] [Related]
15. Low-Zone IL-2 Signaling: Fusion Proteins Containing Linked CD25 and IL-2 Domains Sustain Tolerogenic Vaccination
DeOca KB; Moorman CD; Garcia BL; Mannie MD
Front Immunol; 2020; 11():541619. PubMed ID: 33072087
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. III. A role for anergy/deletion.
Tan LJ; Vanderlugt CL; McRae BL; Miller SD
Autoimmunity; 1998; 27(1):13-28. PubMed ID: 9482204
[TBL] [Abstract][Full Text] [Related]
17. Coaxing the liver into preventing autoimmune disease in the brain.
Hoffman BE; Herzog RW
J Clin Invest; 2008 Oct; 118(10):3271-3. PubMed ID: 18802483
[TBL] [Abstract][Full Text] [Related]
18. Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.
Kleist C; Mohr E; Gaikwad S; Dittmar L; Kuerten S; Platten M; Mier W; Schmitt M; Opelz G; Terness P
J Transl Med; 2016 May; 14(1):99. PubMed ID: 27131971
[TBL] [Abstract][Full Text] [Related]
19. Treatment of experimental autoimmune encephalomyelitis with engineered bi-specific Foxp3+ regulatory CD4+ T cells.
Malviya M; Saoudi A; Bauer J; Fillatreau S; Liblau R
J Autoimmun; 2020 Mar; 108():102401. PubMed ID: 31948790
[TBL] [Abstract][Full Text] [Related]
20. Cutting edge: in vitro-generated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis.
Faunce DE; Terajewicz A; Stein-Streilein J
J Immunol; 2004 Feb; 172(4):1991-5. PubMed ID: 14764660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
